Several hospital-based investigations have documented liver damage in individuals with COVID-19 in the form of increased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values ranging from 14% to 53% above normal [19,20,21]. This evidence concerns the gene GPT and COVID-19.